Endocannabinoids in the new millennium

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 66, Issue 2-3, 2002, Pages 91-92

  Di Marzo, Vincenzo ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ANANDAMIDE; BRAIN RECEPTOR; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR; CANNABIS; DRONABINOL; G PROTEIN COUPLED RECEPTOR; ICOSANOID; DRUG RECEPTOR; ENDOCANNABINOID; PSYCHOTROPIC AGENT;

APPETITE DISORDER; ARACHIDONIC ACID METABOLISM; DRUG DEPENDENCE; EDITORIAL; FOOD INTAKE; HORMONE RELEASE; HUMAN; ICOSANOID METABOLISM; LOCOMOTION; NEUROCHEMISTRY; PAIN ASSESSMENT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; ARTICLE; BRAIN LEVEL; DRUG POTENTIATION; METABOLISM;

CANNABIS;

BRAIN CHEMISTRY; CANNABINOIDS; EICOSANOIDS; ENDOCANNABINOIDS; PSYCHOTROPIC DRUGS; RECEPTORS, CANNABINOID; RECEPTORS, DRUG;

EID: 0036019379     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1054/plef.2001.0339     Document Type: Editorial

References (4)

1. Isolation, structure and partial synthesis of an active constitute of hashish
2. Structure of a cannabinoid receptor and functional expression of the cloned cDNA
3. Isolation and structure of a brain constituent that binds to the cannabinoid receptor
4. Anandamide, an endogenous cannabinomimetic eicosanoid: 'Killing two birds with one stone'